The overall goal of this research is to understand the regulation of bone and cartilage cell growth and specialization. Ongoing in vitro studies using osteoblast-like cells and chondrocytes isolated from the calvaria of rat fetuses as experimental models have yielded two observations which have generated our present specific aims. First, in testing the hypothesis that cells of the monocyte-macrophage series regulate bone formation, we have found that macrophages elaborate a bone cell and chondrocyte mitogenic protein (macrophage-derived growth factor, MDGF). Second, in exploring possible mechanisms for the activation of bone remodeling, we found that certain agents, including prostaglandins of the E series, cause acute alterations in bone cell shape and cell-cell contact which may facilitate activation and intercellular communication.
The specific aims of this proposal extend each of these lines of inquiry. We will: a) undertake the purification to homogeneity and characterization of MDGF from incubation media conditioned by a macrophage-like cell line (monoclonal antibodies will be prepared to MDGF, in order to aid in its purification, its detection in cells and in biological fluids, and in understanding its mode of action); b) study specific macrophage subtypes and macrophage-like cell lines engaged in MDGF synthesis; c) explore the regulation of MDGF synthesis by humoral agents (such as prostaglandins, glucocorticoids, estrogens, 1 Alpha,25(OH)2 vitamin D3) and by non-humoral manipulations (exposure to bone tissue and its components, and lymphokines); and d) examine the nature of bone cell and chondrocyte responses to MDGF and the effect of MDGF on bone resorption. We will probe the mechanisms of and relationships among bone cell shape change, collagenase production and gap junction formation in response to osteotropic hormones. These studies are expected to enhance our knowledge of bone formation, remodeling and repair, so crucial to understanding skeletal disease, and could lead to novel strategies for disease prevention and treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR019855-11
Application #
3155083
Study Section
General Medicine B Study Section (GMB)
Project Start
1978-08-01
Project End
1989-07-31
Budget Start
1988-02-01
Budget End
1989-07-31
Support Year
11
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Barnes-Jewish Hospital
Department
Type
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63110
Shen, V; Cheng, S L; Kohler, N G et al. (1990) Characterization and hormonal modulation of IL-1 binding in neonatal mouse osteoblastlike cells. J Bone Miner Res 5:507-15
Shen, V; Kohler, G; Huang, J et al. (1989) An acidic fibroblast growth factor stimulates DNA synthesis, inhibits collagen and alkaline phosphatase synthesis and induces resorption in bone. Bone Miner 7:205-19
Pacifici, R; Rifas, L; McCracken, R et al. (1989) Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A 86:2398-402
Rifas, L; Cheng, S L; Shen, V et al. (1989) Monokines produced by macrophages stimulate the growth of osteoblasts. Connect Tissue Res 23:163-78
Rifas, L; Halstead, L R; Peck, W A et al. (1989) Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products. J Clin Invest 84:686-94
Shen, V; Kohler, G; Jeffrey, J J et al. (1988) Bone-resorbing agents promote and interferon-gamma inhibits bone cell collagenase production. J Bone Miner Res 3:657-66